{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:19:25Z","timestamp":1792700365724,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/jhg.2016.119","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T06:58:26Z","timestamp":1475737106000},"page":"135-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["INPPL1 gene mutations in opsismodysplasia"],"prefix":"10.1038","volume":"62","author":[{"given":"Ana\u00efs","family":"Fradet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"key":"BFjhg2016119_CR1","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/ajmg.a.37365","volume":"167A","author":"L Bonafe","year":"2015","unstructured":"Bonafe, L., Cormier-Daire, V., Hall, C., Lachman, R., Mortier, G., Mundlos, S. et al. Nosology and classification of genetic skeletal disorders: 2015 revision. Am. J. Med. Genet. A 167A, 2869\u20132892 (2015).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFjhg2016119_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00256-008-0623-4","volume":"38","author":"A Al Kaissi","year":"2009","unstructured":"Al Kaissi, A., Chehida, F. B., Ghachem, M. B., Grill, F. & Klaushofer, K. Atlanto-axial segmentation defects and os odontoideum in two male siblings with opsismodysplasia. Skeletal Radiol. 38, 293\u2013296 (2009).","journal-title":"Skeletal Radiol."},{"key":"BFjhg2016119_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/ajmg.1320490321","volume":"49","author":"FA Beemer","year":"1994","unstructured":"Beemer, F. A. & Kozlowski, K. S. Additional case of opsismodysplasia supporting autosomal recessive inheritance. Am. J. Med. Genet. 49, 344\u2013347 (1994).","journal-title":"Am. J. Med. Genet."},{"key":"BFjhg2016119_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajhg.2012.11.011","volume":"92","author":"JE Below","year":"2013","unstructured":"Below, J. E., Earl, D. L, Shively, K. M ., McMillin, M. J., Smith, J. D., Turner, E. H. et al. Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia. Am. J. Hum. Genet. 92, 137\u2013143 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg2016119_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jmg.40.3.195","volume":"40","author":"V Cormier-Daire","year":"2003","unstructured":"Cormier-Daire, V., Delezoide, A. L., Philip, N., Marcorelles, P., Casas, K., Hillion, Y. et al. Clinical, radiological, and chondro-osseous findings in opsismodysplasia: survey of a series of 12 unreported cases. J. Med. Genet. 40, 195\u2013200 (2003).","journal-title":"J. Med. Genet."},{"key":"BFjhg2016119_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ajhg.2012.11.015","volume":"92","author":"C Huber","year":"2013","unstructured":"Huber, C., Faqeih, E. A., Bartholdi, D., Bole-Feysot, C., Borochowitz, Z., Cavalcanti, D. P. et al. Exome sequencing identifies INPPL1 mutations as a cause of opsismodysplasia. Am. J. Hum. Genet. 92, 144\u2013149 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg2016119_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/jhg.2013.25","volume":"58","author":"A Iida","year":"2013","unstructured":"Iida, A., Okamoto, N., Miyake, N., Nishimura, G., Minami, S., Sugimoto, T. et al. Exome sequencing identifies a novel INPPL1 mutation in opsismodysplasia. J. Hum. Genet. 58, 391\u2013394 (2013).","journal-title":"J. Hum. Genet."},{"key":"BFjhg2016119_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s12098-010-0043-z","volume":"77","author":"LE Lewis","year":"2010","unstructured":"Lewis, L. E., Ramesh Bhat, Y., Naik, P., Sethi, K. & Girisha, K. M. Opsismodysplasia. Indian J. Pediatr. 77, 567\u2013568 (2010).","journal-title":"Indian J. Pediatr."},{"key":"BFjhg2016119_CR9","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/ajmg.a.36640","volume":"164A","author":"B Li","year":"2014","unstructured":"Li, B., Krakow, D., Nickerson, D. A., Bamshad, M. J. University of Washington Center for Mendelian Genomics Chang, Y. et al. Opsismodysplasia resulting from an insertion mutation in the SH2 domain, which destabilizes INPPL1. Am. J. Med. Genet. A 164A, 2407\u20132411 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFjhg2016119_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ajmg.1320190117","volume":"19","author":"P Maroteaux","year":"1984","unstructured":"Maroteaux, P., Stanescu, V., Stanescu, R., Le Marec, B., Moraine, C. & Lejarraga, H. Opsismodysplasia: a new type of chondrodysplasia with predominant involvement of the bones of the hand and the vertebrae. Am. J. Med. Genet. 19, 171\u2013182 (1984).","journal-title":"Am. J. Med. Genet."},{"key":"BFjhg2016119_CR11","first-page":"222","volume":"4","author":"HG Santos","year":"1995","unstructured":"Santos, H. G. & Saraiva, J. M. Opsismodysplasia: another case and literature review. Clin. Dysmorphol. 4, 222\u2013226 (1995).","journal-title":"Clin. Dysmorphol."},{"key":"BFjhg2016119_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/(SICI)1096-8628(19990305)83:1<47::AID-AJMG9>3.0.CO;2-5","volume":"83","author":"K Tyler","year":"1999","unstructured":"Tyler, K., Sarioglu, N. & Kunze, J. Five familial cases of opsismodysplasia substantiate the hypothesis of autosomal recessive inheritance. Am. J. Med. Genet. 83, 47\u201352 (1999).","journal-title":"Am. J. Med. Genet."},{"key":"BFjhg2016119_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/JPEM.2007.20.1.79","volume":"20","author":"MD Zeger","year":"2007","unstructured":"Zeger, M. D., Adkins, D., Fordham, L. A., White, K. E., Schoenau, E., Rauch, F. et al. Hypophosphatemic rickets in opsismodysplasia. J. Pediatr. Endocrinol. Metab. 20, 79\u201386 (2007).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"BFjhg2016119_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1440-1673.1997.tb00465.x","volume":"41","author":"J Zeman","year":"1997","unstructured":"Zeman, J., Baxova, A., Houstkova, H. & Kozlowski, K. Opsismodysplasia: a case report. Australas. Radiol. 41, 35\u201337 (1997).","journal-title":"Australas. Radiol."},{"key":"BFjhg2016119_CR15","first-page":"155","volume":"13","author":"J Zonana","year":"1977","unstructured":"Zonana, J., Rimoin, D. L., Lachman, R. S. & Cohen, A. H. A unique chondrodysplasia secondary to a defect in chondroosseous transformation. Birth Defects Orig. Artic. Ser. 13, 155\u2013163 (1977).","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"BFjhg2016119_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fped.2015.00048","volume":"3","author":"A Khwaja","year":"2015","unstructured":"Khwaja, A., Parnell, S. E., Ness, K., Bompadre, V. & White, K. K. Opsismodysplasia: phosphate wasting osteodystrophy responds to bisphosphonate therapy. Front. Pediatr. 3, 48 (2015).","journal-title":"Front. Pediatr."},{"key":"BFjhg2016119_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCD.0000000000000136","volume":"25","author":"C Feist","year":"2016","unstructured":"Feist, C., Holden, P. & Fitzgerald, J. Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasia. Clin. Dysmorphol. 25, 152\u2013155 (2016).","journal-title":"Clin. Dysmorphol."},{"key":"BFjhg2016119_CR18","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/jcb.23146","volume":"112","author":"C Erneux","year":"2011","unstructured":"Erneux, C., Edimo, W. E., Deneubourg, L. & Pirson, I. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P(3) level, a positive control of PtdIns(3,4)P(2) production, and intrinsic docking properties. J. Cell Biochem. 112, 2203\u20132209 (2011).","journal-title":"J. Cell Biochem."},{"key":"BFjhg2016119_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0065-2571(02)00043-2","volume":"43","author":"K Backers","year":"2003","unstructured":"Backers, K., Blero, D., Paternotte, N., Zhang, J. & Erneux, C. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases. Adv. Enzyme Regul. 43, 15\u201328 (2003).","journal-title":"Adv. Enzyme Regul."},{"key":"BFjhg2016119_CR20","doi-asserted-by":"publisher","first-page":"18605","DOI":"10.1074\/jbc.273.29.18605","volume":"273","author":"T Habib","year":"1998","unstructured":"Habib, T., Hejna, J. A., Moses, R. E. & Decker, S. J. Growth factors and insulin stimulate tyrosine phosphorylation of the 51C\/SHIP2 protein. J. Biol. Chem. 273, 18605\u201318609 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFjhg2016119_CR21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1006\/bbrc.1997.7538","volume":"239","author":"X Pesesse","year":"1997","unstructured":"Pesesse, X., Deleu, S., De Smedt, F., Drayer, L. & Erneux, C. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem. Biophys. Res. Commun. 239, 697\u2013700 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFjhg2016119_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1517\/14728222.2010.492780","volume":"14","author":"A Suwa","year":"2010","unstructured":"Suwa, A., Kurama, T. & Shimokawa, T. SHIP2 and its involvement in various diseases. Expert Opin. Ther. Targets 14, 727\u2013737 (2010).","journal-title":"Expert Opin. Ther. Targets"},{"key":"BFjhg2016119_CR23","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.2337\/diabetes.53.7.1900","volume":"53","author":"PJ Kaisaki","year":"2004","unstructured":"Kaisaki, P. J., Del\u00e9pine, M., Woon, P. Y., Sebag-Montefiore, L., Wilder, S. P., Menzel, S. et al. Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. Diabetes 53, 1900\u20131904 (2004).","journal-title":"Diabetes"},{"key":"BFjhg2016119_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/01.mpa.0000222317.82231.16","volume":"33","author":"S Ishida","year":"2006","unstructured":"Ishida, S., Funakoshi, A., Miyasaka, K., Shimokata, H., Ando, F., Takiguchi, S. et al. Association of SH-2 containing inositol 5'-phosphatase 2 gene polymorphisms and hyperglycemia. Pancreas 33, 63\u201367 (2006).","journal-title":"Pancreas"},{"key":"BFjhg2016119_CR25","first-page":"129","volume":"19","author":"YM Hao","year":"2015","unstructured":"Hao, Y. M., Liu, Q. J., Wang, R. Y., Cao, Y. P., Zhang, Y. & Zuo, L. F. Single nucleotide polymorphisms on SHIP2 is associated with type 2 diabetes mellitus in Chinese Han population. Eur. Rev. Med. Pharmacol. Sci. 19, 129\u2013137 (2015).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"BFjhg2016119_CR26","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2337\/diabetes.51.7.2012","volume":"51","author":"E Marion","year":"2002","unstructured":"Marion, E., Kaisaki, P. J., Pouillon, V., Gueydan, C., Levy, J. C., Bodson, A. et al. The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 51, 2012\u20132017 (2002).","journal-title":"Diabetes"},{"key":"BFjhg2016119_CR27","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1210\/jc.2004-1724","volume":"90","author":"S Kagawa","year":"2005","unstructured":"Kagawa, S., Sasaoka, T., Yaguchi, S., Ishihara, H., Tsuneki, H., Murakami, S. et al. Impact of SRC homology 2-containing inositol 5'-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. J. Clin. Endocrinol. Metab. 90, 2911\u20132919 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg2016119_CR28","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1476-5381.2009.00358.x","volume":"158","author":"A Suwa","year":"2009","unstructured":"Suwa, A., Yamamoto, T., Sawada, A., Minoura, K., Hosogai, N., Tahara, A. et al. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2. Br. J. Pharmacol. 158, 879\u2013887 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"BFjhg2016119_CR29","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1210\/me.2002-0083","volume":"16","author":"H Ishihara","year":"2002","unstructured":"Ishihara, H., Sasaoka, T., Ishiki, M., Wada, T., Hori, H., Kagawa, S. et al. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors. Mol. Endocrinol. 16, 2371\u20132381 (2002).","journal-title":"Mol. Endocrinol."},{"key":"BFjhg2016119_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2174\/138620709789104870","volume":"12","author":"DA Annis","year":"2009","unstructured":"Annis, D. A., Cheng, C. C., Chuang, C. C., McCarter, J. D., Nash, H. M., Nazef, N. et al. Inhibitors of the lipid phosphatase SHIP2 discovered by high-throughput affinity selection-mass spectrometry screening of combinatorial libraries. Comb. Chem. High Throughput Screen. 12, 760\u2013771 (2009).","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"BFjhg2016119_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/carcin\/bgm213","volume":"29","author":"NK Prasad","year":"2008","unstructured":"Prasad, N. K., Tandon, M., Badve, S., Snyder, P. W. & Nakshatri, H. Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover. Carcinogenesis 29, 25\u201334 (2008).","journal-title":"Carcinogenesis"},{"key":"BFjhg2016119_CR32","first-page":"97","volume":"34","author":"NK Prasad","year":"2009","unstructured":"Prasad, N. K. SHIP2 phosphoinositol phosphatase positively regulates EGFR-Akt pathway, CXCR4 expression, and cell migration in MDA-MB-231 breast cancer cells. Int. J. Oncol. 34, 97\u2013105 (2009).","journal-title":"Int. J. Oncol."},{"key":"BFjhg2016119_CR33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000172970","volume":"29","author":"NK Prasad","year":"2008","unstructured":"Prasad, N. K., Tandon, M., Handa, A., Moore, G. E., Babbs, C. F., Snyder, P. W. et al. High expression of obesity-linked phosphatase SHIP2 in invasive breast cancer correlates with reduced disease-free survival. Tumour Biol. 29, 330\u2013341 (2008).","journal-title":"Tumour Biol."},{"key":"BFjhg2016119_CR34","first-page":"218968","volume":"2014","author":"J Yang","year":"2014","unstructured":"Yang, J., Fu, M., Ding, Y., Weng, Y., Fan, W., Pu, X. et al. High SHIP2 expression indicates poor survival in colorectal cancer. Dis. Markers 2014, 218968 (2014).","journal-title":"Dis. Markers"},{"key":"BFjhg2016119_CR35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.arcmed.2011.10.012","volume":"42","author":"X Zhou","year":"2011","unstructured":"Zhou, X., Liu, Y. & Tan, G. Prognostic value of elevated SHIP2 expression in laryngeal squamous cell carcinoma. Arch. Med. Res. 42, 589\u2013595 (2011).","journal-title":"Arch. Med. Res."},{"key":"BFjhg2016119_CR36","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00535-015-1101-0","volume":"51","author":"Y Ye","year":"2015","unstructured":"Ye, Y., Ge, Y. M., Xiao, M. M., Guo, L. M., Li, Q., Hao, J. Q. et al. Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt. J. Gastroenterol. 51, 230\u2013240 (2015).","journal-title":"J. Gastroenterol."},{"key":"BFjhg2016119_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2119\/molmed.2011.00178","volume":"18","author":"GM Fuhler","year":"2012","unstructured":"Fuhler, G. M., Brooks, R., Toms, B., Iyer, S., Gengo, E. A., Park, M. Y. et al. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer. Mol. Med. 18, 65\u201375 (2012).","journal-title":"Mol. Med."},{"key":"BFjhg2016119_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.tcb.2008.04.005","volume":"18","author":"L Stalder","year":"2008","unstructured":"Stalder, L. & Muhlemann, O. The meaning of nonsense. Trends Cell Biol. 18, 315\u2013321 (2008).","journal-title":"Trends Cell Biol."},{"key":"BFjhg2016119_CR39","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","volume":"31","author":"Y Choi","year":"2015","unstructured":"Choi, Y. & Chan, A. P. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 31, 2745\u20132747 (2015).","journal-title":"Bioinformatics"},{"key":"BFjhg2016119_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248\u2013249 (2010).","journal-title":"Nat. Methods"},{"key":"BFjhg2016119_CR41","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073\u20131081 (2009).","journal-title":"Nat. Protoc."},{"key":"BFjhg2016119_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajhg.2012.11.011","volume":"92","author":"JE Below","year":"2013","unstructured":"Below, J. E., Earl, D. L., Shively, K. M., McMillin, M. J., Smith, J. D., Turner, E. H. et al. Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia. Am. J. Hum. Genet. 92, 137\u2013143 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg2016119_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/humu.21391","volume":"32","author":"H Hichri","year":"2011","unstructured":"Hichri, H., Rendu, J., Monnier, N., Coutton, C., Dorseuil, O., Poussou, R. V. et al. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum. Mutat. 32, 379\u2013388 (2011).","journal-title":"Hum. Mutat."},{"key":"BFjhg2016119_CR44","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1002\/ajmg.a.37173","volume":"167A","author":"H Lee","year":"2015","unstructured":"Lee, H., Nevarez, L., Lachman, R. S., Wilcox, W. R., Krakow, D., Cohn, D. H. et al. A second locus for schneckenbecken dysplasia identified by a mutation in the gene encoding inositol polyphosphate phosphatase-like 1 (INPPL1). Am. J. Med. Genet. A 167A, 2470\u20132473 (2015).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFjhg2016119_CR45","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/jmg.2008.065201","volume":"46","author":"T Furuichi","year":"2009","unstructured":"Furuichi, T., Kayserili, H., Hiraoka, S., Nishimura, G., Ohashi, H., Alanay, Y. et al. Identification of loss-of-function mutations of SLC35D1 in patients with Schneckenbecken dysplasia, but not with other severe spondylodysplastic dysplasias group diseases. J. Med. Genet. 46, 562\u2013568 (2009).","journal-title":"J. Med. Genet."},{"key":"BFjhg2016119_CR46","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/nm1655","volume":"13","author":"S Hiraoka","year":"2007","unstructured":"Hiraoka, S., Furuichi, T., Nishimura, G., Shibata, S., Yanagishita, M., Rimoin, D. L. et al. Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human. Nat. Med. 13, 1363\u20131367 (2007).","journal-title":"Nat. Med."},{"key":"BFjhg2016119_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","volume":"7","author":"DR Alessi","year":"1997","unstructured":"Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B. et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr. Biol. 7, 261\u2013269 (1997).","journal-title":"Curr. Biol."},{"key":"BFjhg2016119_CR48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.bone.2009.08.003","volume":"45","author":"V Ulici","year":"2009","unstructured":"Ulici, V., Hoenselaar, K. D., Agoston, H., McErlain, D. D., Umoh, J., Chakrabarti, S. et al. The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification. Bone 45, 1133\u20131145 (2009).","journal-title":"Bone"},{"key":"BFjhg2016119_CR49","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1101\/gad.1089403","volume":"17","author":"XD Peng","year":"2003","unstructured":"Peng, X. D., Xu, P. Z., Chen, M. L., Hahn-Windgassen, A., Skeen, J., Jacobs, J. et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17, 1352\u20131365 (2003).","journal-title":"Genes Dev."},{"key":"BFjhg2016119_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nm1178","volume":"11","author":"MW Sleeman","year":"2005","unstructured":"Sleeman, M. W., Wortley, K. E., Lai, K. M., Gowen, L. C., Kintner, J., Kline, W. O. et al. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat. Med. 11, 199\u2013205 (2005).","journal-title":"Nat. Med."},{"key":"BFjhg2016119_CR51","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1242\/dev.040592","volume":"136","author":"MJ Ahrens","year":"2009","unstructured":"Ahrens, M. J., Li, Y., Jiang, H. & Dudley, A. T. Convergent extension movements in growth plate chondrocytes require gpi-anchored cell surface proteins. Development 136, 3463\u20133474 (2009).","journal-title":"Development"},{"key":"BFjhg2016119_CR52","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1091\/mbc.e12-08-0626","volume":"24","author":"A Awad","year":"2013","unstructured":"Awad, A., Sar, S., Barr\u00e9, R., Cariven, C., Marin, M., Salles, J. P. et al. SHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core protein. Mol. Biol. Cell 24, 2171\u20132185 (2013).","journal-title":"Mol. Biol. Cell"},{"key":"BFjhg2016119_CR53","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1091\/mbc.e11-11-0958","volume":"23","author":"K Kato","year":"2012","unstructured":"Kato, K., Yazawa, T., Taki, K., Mori, K., Wang, S., Nishioka, T. et al. The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration. Mol. Biol. Cell 23, 2593\u20132604 (2012).","journal-title":"Mol. Biol. Cell"},{"key":"BFjhg2016119_CR54","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1242\/dmm.000703","volume":"3","author":"MJ Jurynec","year":"2010","unstructured":"Jurynec, M. J. & Grunwald, D. J. SHIP2, a factor associated with diet-induced obesity and insulin sensitivity, attenuates FGF signaling in vivo. Dis. Model Mech. 3, 733\u2013742 (2010).","journal-title":"Dis. Model Mech."},{"key":"BFjhg2016119_CR55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/03008207.2015.1051224","volume":"56","author":"J Narayana","year":"2015","unstructured":"Narayana, J. & Horton, W. A. FGFR3 biology and skeletal disease. Connect. Tissue Res. 56, 427\u2013433 (2015).","journal-title":"Connect. Tissue Res."},{"key":"BFjhg2016119_CR56","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCD.0000000000000136","volume":"25","author":"C Feist","year":"2016","unstructured":"Feist, C., Holden, P. & Fitzgerald, J. Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasia. Clin. Dysmorphol. 25, 152\u2013155 (2016).","journal-title":"Clin. Dysmorphol."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhg2016119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhg2016119","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhg2016119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T02:56:23Z","timestamp":1641005783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg2016119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFjhg2016119"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2016.119","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]},"assertion":[{"value":"30 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}